Ceevra, Inc.

Ceevra, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on April 25, 2023 and the most recent on March 4, 2025 (Ceevra Reveal 3+). Its most common review panel is Radiology (3 devices).